ArticlePublished 2012

Case Reports: Aripripazole Reduces Risperidone-Induced Hyperprolactinemia

Authors: Walter Milano, Luca Milano, Claudio Petrella, Andrea Ingenito, Anna Capasso

Biomedical Research

Volume 23 · Issue 3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Many schizophrenic patients treated with typical or atypical antipsychotics (AP) such as risperidone show significant clinical alterations as changes in sexual activity, menstrual cycle, amenorrhea, galattorrea and cardiovascular disorders because of AP-induced hyperprolactinemia. In the present paper we report two clinical cases showing, after switching with aripiprazole, a PRL normalization and a marked improvement of clinical events related to risperidone- induced hyperprolactinemia

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Allied Academies does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Walter Milano”
  • BylineArticles whose byline prints “Luca Milano”
  • BylineArticles whose byline prints “Claudio Petrella”
  • BylineArticles whose byline prints “Andrea Ingenito”
  • BylineArticles whose byline prints “Anna Capasso”